Antidote.me logo

Antidote.me

Antidote.me closes the gap between clinical trials and patients

5

Funding Rounds

$28.9m

Money raised

Overview

Antidote.me closes the gap between clinical trials and patients

Funding series

Funding Series Analysis

The company Antidote.me has raised a total of $1.2m in funding over 5 rounds.

Key Insights:

  • Antidote.me - Venture Funding Round - October, 2011: $1.2m
  • Antidote.me Venture Funding Round, September 2017: $11m
  • Antidote.me - Series A Funding Round - May, 2013: $3.2m
  • Antidote.me - Series B Funding Round - February, 2015: $13.5m
Antidote.me logo
Antidote.me - Venture Funding Round - October, 2011 $1.2m
Antidote.me logo
Antidote.me Venture Funding Round, September 2017 $11m
Antidote.me logo
Antidote.me - Series A Funding Round - May, 2013 $3.2m
Antidote.me logo
Antidote.me - Series B Funding Round - February, 2015 $13.5m

Industries

Antidote.me is active in the following industries:
  • Autoimmune disease
  • Health information technology
  • Drug discovery
  • Artificial Intelligence (AI)
  • Healthcare
  • Clinical trial
  • Telehealth
  • Decentralized clinical trial
  • Digital health
  • Technology